Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 22052888.
- Also identified by DOI 10.1093/cid/cir755.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 118 previous hepatitis B surface antigen (HBsAg) carriers, low-level hepatitis B (HBV) viremia persisted at a rate of 15%-20% for >10 years after HBsAg seroclearance. The frequency of HBV viremia was significantly (P = .002) lower in patients with anti-HBsAg seroconversion (6 of 69 [8.7%]) than in those without seroconversion (15 of 49 [30.6%]).
Medical subject headings
- Carrier State
- Hepatitis B Surface Antigens
- Hepatitis B virus
- Hepatitis B, Chronic
- Viremia